Does CABOZANTINIB S-MALATE Cause Hyponatraemia? 118 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Hyponatraemia have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.3% of all adverse event reports for CABOZANTINIB S-MALATE.
118
Reports of Hyponatraemia with CABOZANTINIB S-MALATE
0.3%
of all CABOZANTINIB S-MALATE reports
28
Deaths
85
Hospitalizations
How Dangerous Is Hyponatraemia From CABOZANTINIB S-MALATE?
Of the 118 reports, 28 (23.7%) resulted in death, 85 (72.0%) required hospitalization, and 7 (5.9%) were considered life-threatening.
Is Hyponatraemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 118 reports have been filed with the FAERS database.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Hyponatraemia?
FUROSEMIDE (3,127)
HYDROCHLOROTHIAZIDE (2,138)
OMEPRAZOLE (1,635)
LANSOPRAZOLE (1,416)
SERTRALINE (1,332)
RAMIPRIL (1,178)
SPIRONOLACTONE (1,166)
PANTOPRAZOLE (1,134)
INDAPAMIDE (976)
AMLODIPINE (879)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Hyponatraemia Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE